William Brown
Principal investigator, leads Lumedica, Inc.
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$3.2MFederal grants as PI9 awards
1Patents grantedLatest Dec 18, 2018
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
9 awards · $3.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 18, 2021 | NIH | STTR Phase I Low Cost Spectroscopic OCT for GI Applications | $256K | Lumedica, Inc |
| 2021 | NIH | SBIR Phase I Low Cost OCT Angiography with Spectroscopic Contrast | $259K | Lumedica, Inc |
| Dec 14, 2020 | NIH | SBIR Phase I Low Cost OCT Angiography with Spectroscopic Contrast | $259K | Lumedica, Inc |
| Sep 11, 2020 | NSF | SBIR Phase II SBIR Phase II: Extended depth imaging with optical coherence tomography (OCT) | $999K | Lumedica, Inc |
| Jun 22, 2020 | NIH | SBIR Phase II Low cost retinal optical coherence tomography for point of care use | $500K | Lumedica, Inc |
| Jul 1, 2019 | NIH | SBIR Phase II Low cost retinal optical coherence tomography for point of care use | $500K | Lumedica, Inc |
| Jul 9, 2018 | NSF | SBIR Phase I SBIR Phase I: Extended depth imaging with OCT | $225K | Lumedica, Inc |
| Sep 14, 2017 | NIH | SBIR Phase I Low cost retinal optical coherence tomography for point of care use | $25K | Lumedica, Inc |
| Aug 30, 2016 | NIH | SBIR Phase I Low cost retinal optical coherence tomography for point of care use | $183K | Lumedica, Inc |
2 patents as inventor
- US 10156434Lumedica, IncDec 18, 2018
- US Lumedica, Inc—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#597
Awards as PI#166
Patents#284
Companies
- Lumedica, IncLeads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.